Why is it important Semaglutide supports sustained weight loss and improve metabolic health
It is worth noting that for currently licensed GLP-1 receptor agonists in the UK, the thyroid tumour signal is classified as a precautionary consideration based on rodent data, rather than a formal contraindication as reflected in UK Summaries of Product Characteristics (SmPCs)
Professional medical evaluation may be appropriate when: Facial hollowing or volume loss is the primary concern Skin laxity is significant There is persistent redness, itching, pain, or a new rash Hair shedding becomes pronounced or continues for several months Dryness is severe despite a simplified routine A changing lesion or pigmented spot requires evaluation The individual is considering injectable or energy-based procedures Consumers should not stop, reduce, or change a prescribed GLP-1 medication because of cosmetic concerns without speaking with the healthcare professional managing their treatment
They target different receptors and were designed to be complementary which is exactly why cagrilintide is studied in combination with an incretin (semaglutide) rather than against one
In: Office of disease prevention and health promotion USDoHaHS, ed
Systematic monitoring of objective parameters provides the most reliable assessment of semaglutide efficacy
